Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0000
0.0000
(0.00%)
At close: February 3 at 8:08:30 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-34,796
-39,892
-35,457
-18,851
-16,054
Investing Cash Flow
43,325
14,998
-53,866
12,891
-55
Financing Cash Flow
-8,258
438
22,542
62,425
44,980
End Cash Position
13,127
12,317
36,773
103,554
47,089
Interest Paid Supplemental Data
3,131
3,070
454
343
115
Capital Expenditure
-64
-138
-45
-4,252
-55
Issuance of Capital Stock
252
299
2,331
62,320
39,720
Issuance of Debt
--
--
19,986
--
5,260
Repayment of Debt
--
--
--
-234
--
Free Cash Flow
-34,796
-40,030
-35,502
-23,103
-16,109
12/31/2020 - 3/4/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
0M4.DU Mersana Therapeutics Inc
0.4706
-5.35%
8AW0.F Ocean Biomedical, Inc.
0.0860
-3.37%
8AW0.BE Ocean Biomedical Inc
0.0945
-2.07%
8AW0.MU Ocean Biomedical Inc
0.0965
-3.50%
0M4.SG Mersana Therapeutics Inc
0.4769
-1.22%
0S90.BE Syros Pharmaceuticals Inc
0.1380
-3.50%
0S90.MU Syros Pharmaceuticals Inc
0.1440
-5.88%
AT20.F Atara Biotherapeutics, Inc.
6.55
-5.76%
8AW0.SG Ocean Biomedical Inc
0.0915
+0.55%
NV4.F Cellectar Biosciences, Inc.
0.2800
+6.87%